Phenylketonuria Treatment Market Will Reflect Significant Growth ... - Digital Journal
| ERYPDelisted Stock | USD 0.78 0.04 4.88% |
Slightly above 62% of Erytech Pharma's investor base is looking to short. The analysis of current outlook of investing in Erytech Pharma SA suggests that many traders are alarmed regarding Erytech Pharma's prospects. Erytech Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Erytech Pharma SA. Many technical investors use Erytech Pharma SA stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Erytech |
Phenylketonuria Treatment Market Will Reflect Significant Growth ... Digital Journal
Read at news.google.com
 |
Erytech Pharma Fundamental Analysis
We analyze Erytech Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Erytech Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Erytech Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Erytech Pharma is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Erytech Pharma SA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Erytech Pharma stock to make a market-neutral strategy. Peer analysis of Erytech Pharma could also be used in its relative valuation, which is a method of valuing Erytech Pharma by comparing valuation metrics with similar companies.
Peers
Erytech Pharma Related Equities
| SRZN | Surrozen | 19.37 | ||||
| XRTX | XORTX Therapeutics | 4.96 | ||||
| ATXI | Avenue Therapeutics | 4.37 | ||||
| IKNA | Ikena Oncology | 2.37 | ||||
| UNCY | Unicycive Therapeutics | 1.47 | ||||
| ADXN | Addex Therapeutics | 1.04 | ||||
| SNGX | Soligenix | 0.60 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| NTRB | Nutriband | 1.03 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| GNFT | Genfit | 1.41 | ||||
| ARMP | Armata Pharmaceuticals | 2.13 | ||||
| HCWB | HCW Biologics | 6.00 | ||||
| XCUR | Exicure | 7.81 | ||||
| APM | Aptorum Group | 8.45 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Erytech Stock
If you are still planning to invest in Erytech Pharma SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Erytech Pharma's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |